This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

A Clinical Study of Two Hundred and Thirty-Eight Cases

MERRILL J. KING, M.D.

Arch Ophthal. 1950;43(4):694-711.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE TERM "retrolental fibroplasia" was devised in 1941 by Dr. Harry H. Messenger, of Boston, for use by Dr. Theodore L. Terry.¹ Terry² applied the name to an ocular disease syndrome in which, as he stated, vascularized embryonic tissue develops behind the crystalline lens of the eye. Previously, in occasional cases the disease had been reported, under various names, as a rare congenital malformation which was usually observed shortly after birth in full term infants, as a rule only one eye being involved. It was Terry³ who, in 1942, first associated retrolental fibroplasia with prematurity. He² summarized the syndrome as follows:

The typical characteristics of the disease are opaque vascularized membrane behind the lens, microphthalmia, shallow anterior chambers, fetal-blue color of iris, thin ciliary processes in front of the opaque tissue, searching nystagmus, apparent photophobia, persistent hyaloid artery and often retinal separation.

In his series of . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

From the Department of Ophthalmology, Harvard Medical School, and the Massachusetts Eye and Ear Infirmary.

Footnotes
This study was supported in part by a grant from the Foundation for Vision for the Study of Retrolental Fibroplasia.

Read before the Section on Ophthalmology at the Ninety-Eighth Annual Session of the American Medical Association, Atlantic City, N. J., June 9, 1949.